Travere Therapeutics Inc (TVTX)

09:28 AM

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 44.65% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

09:28 AM

Feb 26, 2026

TVTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 26, 2026

Feb 26, 2026

Total debt per share of Travere Therapeutics, Inc. – BOATS:TVTX - TradingView

Feb 26, 2026

Feb 24, 2026

Travere Therapeutics (TVTX) Is Up 7.4% After FILSPARI-Fueled Revenue Surge And Narrower LossesHas The Bull Case Changed? - simplywall.st

Feb 24, 2026

Feb 24, 2026

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A 39% Upside Potential Sparks Investor Interest - DirectorsTalk Interviews

Feb 24, 2026

Feb 24, 2026

Travere Therapeutics (TVTX) CEO sells 60,000 shares in 10b5-1 trade - Stock Titan

Feb 24, 2026

Feb 24, 2026

Analysts Are Bullish on Top Healthcare Stocks: Travere Therapeutics (TVTX), Insmed (INSM) - The Globe and Mail

Feb 24, 2026

Feb 24, 2026

Travere Therapeutics, Inc. (TVTX): A Bull Case Theory - Finviz

Feb 24, 2026

Feb 24, 2026

Travere Therapeutics (TVTX) Reports 144% Annual Growth in Filspari Sales for 2025 - Finviz

Feb 24, 2026

Feb 24, 2026

Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX) - Seeking Alpha

Feb 24, 2026

Feb 23, 2026

A Look At Travere Therapeutics (TVTX) Valuation After Q4 Earnings Beat And FILSPARI Regulatory Progress - Yahoo Finance

Feb 23, 2026

Feb 22, 2026

Assessing Travere Therapeutics (TVTX) Valuation After Strong Earnings Beat And Pipeline Progress - Sahm

Feb 22, 2026

Feb 21, 2026

Bank of America Securities Sticks to Their Buy Rating for Travere Therapeutics (TVTX) - The Globe and Mail

Feb 21, 2026

Feb 21, 2026

Travere Therapeutics (NASDAQ:TVTX) Downgraded by Wall Street Zen to Buy - MarketBeat

Feb 21, 2026

Feb 21, 2026

Travere outlines FILSPARI-driven growth and new FSGS milestone as 2026 begins - MSN

Feb 21, 2026

Feb 20, 2026

Travere Therapeutics Earnings Call Shows Growth Amid Risks - TipRanks

Feb 20, 2026

Feb 20, 2026

TVTX (NASDAQ): Affiliate files Form 144 to sell 60,000 shares - Stock Titan

Feb 20, 2026

Feb 20, 2026

How liquid is Travere Therapeutics Inc. stockJuly 2025 Volume & Daily Chart Pattern Signals - mfd.ru

Feb 20, 2026

Feb 20, 2026

Travere Therapeutics (NASDAQ:TVTX) Shares Down 5.4%Should You Sell? - MarketBeat

Feb 20, 2026

Feb 20, 2026

Travere Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 20, 2026

Feb 20, 2026

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 20, 2026

Feb 20, 2026

Travere Therapeutics Inc (TVTX) Q4 2025 Earnings Call Highlights - GuruFocus

Feb 20, 2026

Feb 20, 2026

Decoding Travere Therapeutics Inc (TVTX): A Strategic SWOT Insig - GuruFocus

Feb 20, 2026

Feb 19, 2026

Travere Therapeutics Q4 Earnings Call Highlights - MarketBeat

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace

Feb 19, 2026

Feb 19, 2026

TVTX: FILSPARI drove record revenue and patient growth in 2025, with strong outlook for 2026 - TradingView

Feb 19, 2026

Feb 19, 2026

Travere (TVTX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates - Yahoo Finance

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics, Inc. SEC 10-K Report - TradingView

Feb 19, 2026

Feb 19, 2026

TVTX: 2025 revenue surged to $490.7M on FILSPARI growth; net loss narrowed and pipeline advanced - TradingView

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics (NASDAQ:TVTX) Announces Quarterly Earnings Results, Beats Estimates By $0.42 EPS - MarketBeat

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss - Investing.com Canada

Feb 19, 2026

Feb 19, 2026

Travere: Fourth Quarter Financial Results Overview - Bitget

Feb 19, 2026

Feb 19, 2026

Travere: Q4 Earnings Snapshot - KVUE

Feb 19, 2026

Feb 19, 2026

Earnings Flash (TVTX) Travere Therapeutics, Inc. Posts Q4 Adjusted EPS $0.37 per Share, vs. FactSet Est of $0.38 - marketscreener.com

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics Q4 Earnings Report: What Investors Need to Know - Benzinga

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics faces earnings test amid FSGS approval delay By Investing.com - Investing.com UK

Feb 19, 2026

Feb 19, 2026

Travere Therapeutics faces earnings test amid FSGS approval delay - Investing.com Australia

Feb 19, 2026

Feb 18, 2026

Stocks with rising relative price strength: Travere Therapeutics - MSN

Feb 18, 2026

Feb 18, 2026

Earnings Outlook For Travere Therapeutics - Benzinga

Feb 18, 2026

Feb 18, 2026

Aberdeen Group plc Acquires 70,791 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat

Feb 18, 2026

Feb 18, 2026

Travere Therapeutics, Inc. (TVTX) Positioned for Long-Term Growth in Rare Disease Market - Finviz

Feb 18, 2026

Feb 17, 2026

Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? - AOL.com

Feb 17, 2026

Feb 17, 2026

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unpacking A 52.25% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026

Feb 17, 2026

How New Filspari Reviews And Price Targets Are Rewriting The Story For Travere Therapeutics (TVTX) - Yahoo Finance

Feb 17, 2026

Feb 16, 2026

Is Travere Therapeutics (TVTX) Still Attractive After Recent Share Price Volatility? - Yahoo Finance

Feb 16, 2026

Feb 16, 2026

Precision Trading with Travere Therapeutics Inc. (TVTX) Risk Zones - Stock Traders Daily

Feb 16, 2026

Feb 16, 2026

15 Innovative Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 16, 2026

Feb 15, 2026

Travere Therapeutics Targets April FSGS FILSPARI Decision as IgAN Sales Accelerate, HCU Trial Restarts - MarketBeat

Feb 15, 2026

Feb 14, 2026

Can Travere Therapeutics Inc. be recession proofJuly 2025 Trade Ideas & Weekly High Conviction Ideas - mfd.ru

Feb 14, 2026